PharmaTher Holdings Ltd. PHRRF
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 456.30K | 566.40K | 589.40K | 625.40K | 675.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 564.10K | 878.70K | 997.10K | 1.09M | 1.09M |
| Operating Income | -564.10K | -878.70K | -997.10K | -1.09M | -1.09M |
| Income Before Tax | -442.00K | -790.60K | -1.05M | -1.14M | -1.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.44 | -0.79 | -1.05 | -1.14 | -1.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -442.00K | -790.60K | -1.05M | -1.14M | -1.09M |
| EBIT | -564.10K | -878.70K | -997.10K | -1.09M | -1.09M |
| EBITDA | -- | -374.70K | -619.20K | -855.30K | -1.09M |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 364.30M | 361.48M | 358.98M | 356.13M | 353.73M |
| Average Diluted Shares Outstanding | 364.30M | 361.48M | 358.98M | 356.13M | 353.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |